UNSPSC 51191535: Brocrinat

This classification denotes a diuretic with the molecular formula C15H9BrFNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6ESF2Z39VZ, chemically known as acetic acid, ((7-bromo-3-(2-fluorophenyl)-1,2-benzisoxazol-6-yl)oxy)- but generally known as brocrinat, which bears US NIH Compound Identifier 51603. European Medicines Agency schedules Brocrinat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05897MIG.

UNSPSC 51191535 Brocrinat is a Commodity code under which state and local governments procure specialized chemical products for water treatment and pharmaceutical supply operations. The recent solicitation activity shows divergence between the code's nominal name and actual procurement scope: while the code nominally references brocrinat, the documented opportunities involve sodium bisulfite for municipal water pollution control and generic multi-source pharmaceuticals and over-the-counter products for state and local health facilities. Issuing bodies soliciting under this code span municipal utilities and state-level cooperative purchasing alliances. The City of Meriden, Connecticut, is procuring sodium bisulfite as a chemical supply for water treatment operations, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is establishing multi-vendor contracts for pharmaceutical and OTC product distribution across participating state and local facilities in multiple states including Oregon. Vendors responding to these opportunities must maintain substantial insurance coverage—General Liability of $1,000,000 to $2,000,000 in the Meriden procurement and $5,000,000 per occurrence in the MMCAP RFP—and comply with regulatory requirements including cGMP certification and FDA compliance for pharmaceutical products.

Recent geographic activity centers on Connecticut and Minnesota, with the MMCAP cooperative extending to Oregon and other participating jurisdictions. The City of Meriden issued an IFB for sodium bisulfite with bids due July 29, 2026, under solicitation B02715, requiring performance and payment bonds and firm pricing for the contract period. MMCAP issued an RFP on January 20, 2026, with proposals due March 26, 2026, under solicitation S1070000015802 to establish multiple contracts for generic pharmaceuticals and OTC products effective July 1, 2026, with vendor selection weighted heavily on price competitiveness (75 percent), contract pricing (10 percent), and administrative compliance including EDI capability and administrative fee agreement (5 percent each). The pharmaceutical RFP mandates vendor relationships with at least two of three authorized wholesalers and allows multiple award options based on member-specific needs. The code shows limited recent activity; the nominal code name does not align with the documented procurement scope, suggesting either misclassification in source systems or that brocrinat procurement has minimal current state and local demand.